Drug Interactions Database

3916 interactions from BNF 85 - Check your medicines

Source: BNF 85
metoclopramide dopaminereceptoragonists

decreases effects

Unknown Study
metoclopramide neuromuscularblockingdrugs,non-depolarising

increases effects

Unknown Theoretical
metoclopramide posaconazole

decreases absorption

Unknown Study
metoclopramide posaconazoleoralsuspension

decreases absorption

Unknown Study
metoclopramide pramipexole

decreases effects

Unknown Study
metoclopramide quinagolide

decreases effects

Unknown Study
metoclopramide ropinirole

decreases effects

Unknown Study
metoclopramide rotigotine

decreases effects

Unknown Study
metoclopramide suxamethonium

increases effects

Unknown Study
metoclopramide topicalprilocaine

increases risk of methaemoglobinaemia

Unknown Theoretical
metolazone methenamine

decreases efficacy

Unknown Theoretical
metreleptin combinedhormonalcontraceptives

decreases efficacy

Unknown Theoretical
metronidazole alkylatingagents

increases risk of toxicity

Unknown Study
metronidazole busulfan

increases risk of toxicity

Unknown Study
metronidazole capecitabine

increases risk of capecitabinetoxicity

Unknown Theoretical
metronidazole fluorouracil

increases risk of toxicity

Unknown Study
mexiletine agomelatine

increases exposure

Unknown Study
mexiletine anaesthetics,local

increases exposure

Unknown Theoretical
mexiletine anagrelide

increases exposure

Unknown Theoretical
mexiletine betablockers,non-selective

increases risk of cardiovascularadverseeffects

Unknown Theoretical
mexiletine calciumchannelblockers

increases risk of cardiovascularadverseeffects

Unknown Theoretical
mexiletine chlorpromazine

increases exposure

Unknown Theoretical
mexiletine diltiazem

increases risk of cardiovascularadverseeffects

Unknown Theoretical
mexiletine duloxetine

increases exposure

Unknown Theoretical
mexiletine loxapine

increases exposure

Unknown Theoretical
mexiletine melatonin

increases exposure

Unknown Theoretical
mexiletine metformin

affects exposure

Unknown Theoretical
mexiletine phenothiazines

increases exposure

Unknown Theoretical
mexiletine phosphodiesterasetype-

increases exposure

Unknown Theoretical
mexiletine rasagiline

increases exposure

Unknown Study
mexiletine riluzole

increases exposure

Unknown Theoretical
mexiletine roflumilast

increases exposure

Unknown Theoretical
mexiletine ropivacaine

increases exposure

Unknown Theoretical
mexiletine triptans

increases exposure

Unknown Theoretical
mexiletine verapamil

increases risk of cardiovascularadverseeffects

Unknown Theoretical
mexiletine zolmitriptan

increases exposure

Unknown Theoretical
mianserin ephedrine

decreases effects

Unknown Anecdotal
mianserin pitolisant

decreases efficacy

Unknown Theoretical
mianserin sympathomimetics,vasoconstrictor

decreases effects

Unknown Anecdotal
micafungin amphotericin

increases exposure

Unknown Study
miconazole aminoglycosides

decreases exposure

Unknown Anecdotal
miconazole cobimetinib

increases exposure

Unknown Theoretical
miconazole diltiazem

increases exposure

Unknown Theoretical
miconazole phenindione

increases anticoagulant effect

Unknown Theoretical
miconazole pimozide

increases exposure

Unknown Theoretical
miconazole tobramycin

decreases exposure

Unknown Anecdotal
midostaurin ciclosporin

increases concentration

Unknown Anecdotal
midostaurin theactivemetaboliteofbupropion

decreases exposure

Unknown Study
mifepristone alfentanil

increases exposure

Unknown Theoretical
mifepristone avatrombopag

increases exposure

Unknown Theoretical
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.